Search research articles
Contact Us
Filters
Showing results (1211-1220 of 1,237) with videos related to
Page
of 124
Sort By:
Endoscopic Ultrasound
|
November 1, 2019
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol
Manoop S Bhutani, Jason B Klapman, Richard Tuli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma
Awalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
BMC Cancer
|
June 13, 2019
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
Alessio G Morganti, Francesco Cellini, Milly Buwenge, et al.
Leukemia & Lymphoma
|
March 11, 2017
Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
Fie J Vojdeman, Sarah E M Herman, Nikolai Kirkby, et al.
The Lancet. Oncology
|
January 4, 2015
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
Mohammed Z H Farooqui, Janet Valdez, Sabrina Martyr, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2017
Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy
Avani D Rao, Yufei Liu, Rie von Eyben, et al.
The New England Journal of Medicine
|
January 4, 2018
Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain
Sergey I Nikolaev, Sandra Vetiska, Ximena Bonilla, et al.
Leukemia & Lymphoma
|
March 3, 2021
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study
Sanjal Desai, Clifton Mo, Erika M Gaglione, et al.
Blood
|
February 28, 2018
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study
Inhye E Ahn, Mohammed Z H Farooqui, Xin Tian, et al.
Journal of Hepatocellular Carcinoma
|
March 10, 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
Brian De, Sweet Ping Ng, Amy Y Liu, et al.
Page
of 124
Search research articles
Search
Showing results (1211-1220 of 1,237) with videos related to
Sort By:
Page
of 124
Endoscopic Ultrasound
|
November 1, 2019
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol
Manoop S Bhutani, Jason B Klapman, Richard Tuli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma
Awalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
BMC Cancer
|
June 13, 2019
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
Alessio G Morganti, Francesco Cellini, Milly Buwenge, et al.
Leukemia & Lymphoma
|
March 11, 2017
Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
Fie J Vojdeman, Sarah E M Herman, Nikolai Kirkby, et al.
The Lancet. Oncology
|
January 4, 2015
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
Mohammed Z H Farooqui, Janet Valdez, Sabrina Martyr, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2017
Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy
Avani D Rao, Yufei Liu, Rie von Eyben, et al.
The New England Journal of Medicine
|
January 4, 2018
Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain
Sergey I Nikolaev, Sandra Vetiska, Ximena Bonilla, et al.
Leukemia & Lymphoma
|
March 3, 2021
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study
Sanjal Desai, Clifton Mo, Erika M Gaglione, et al.
Blood
|
February 28, 2018
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study
Inhye E Ahn, Mohammed Z H Farooqui, Xin Tian, et al.
Journal of Hepatocellular Carcinoma
|
March 10, 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
Brian De, Sweet Ping Ng, Amy Y Liu, et al.
Page
of 124